RSS
Press Releases
Trusted reliable news sources from around the web. We offer special news reports, topic news videos, and related content stories. Truly a birds eye view on news.
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
The Board of Directors today announces the executive leadership team that will lead Bang & Olufsen through the next phase of its strategy execution.
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
EquipmentShare.com (EQPT) Investors Have Opportunity to Lead EquipmentShare.com, Inc. Securities Fraud Lawsuit
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
As FREELANDER continues its global journey, the Super Factory represents the manufacturing foundation behind its premium intelligent mobility vision.
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Pegasystems Inc. (“Pegasystems” or the “Company”) (NASDAQ: PEGA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
- Details
- Written by Send2Press NewsWire
- Category: Send2Press NewsWire Distribution Service
SAN FRANCISCO, Calif., Aug. 11, 2026 (SEND2PRESS NEWSWIRE) -- New data from the HotDeals Research Team shows that during the 2026 Back-to-School season, U.S. shoppers continue to favor manually applied coupon codes over automatically applied, no-code deals. According to the HotDeals Consumer Savings Index, more than 2,000 active Back-to-School promotions were tracked across over 1,000 U.S. merchants this season, with code-based offers outnumbering no-code deals by a wide margin.
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
– Se ha administrado la primera dosis a los pacientes en el estudio clínico VIRAGE2 de Fase IIa, que evalúa la administración con mayor frecuencia de VCN-01 (zabilugene almadenorepvec), cuyo objetivo es mejorar los resultados del tratamiento en pacientes con adenocarcinoma ductal pancreático (PDAC) metastásico –
Globe NewsWire News Distribution Service Article Count: 1424
Media Partner Network Article Count: 4
Send2Press NewsWire Distribution Service Article Count: 504
Related Product Search/Búsqueda de productos relacionados
